Frequency and Distinctive Spectrum of KRAS Mutations in Never Smokers with Lung Adenocarcinoma

Riely et al. (Sun,) studied this question.

www.synapsesocial.com/papers/69de6ce4bf539e22705588db — DOI: https://doi.org/10.1158/1078-0432.ccr-08-0646

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Tobacco Smoke Carcinogens and Lung Cancer· 1999 · 1,974 citations
2. Prospective trial with preoperative gefitinib to correlate lung cancer response with <i>EGFR</i> exon 19 and 21 mutations and to select patients for adjuvant therapy· 2006 · 17 citations
3. At least one in seven cases of cancer is caused by smoking. Global estimates for 1985· 1994 · 283 citations
4. First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations· 2008 · 833 citations
5. Mutations of the <b> <i>Epidermal Growth Factor Receptor</i> </b> Gene in Lung Cancer· 2004 · 1,228 citations